Meet the expert: the role of parp inhibitors in ovarian cancer: first-line treatment algorithm, outcomes, and survival

This “meet the expert” is designed to provide an interactive discussion between faculty and participants, focusing on real-world application of current evidence, treatment decision-making, and management of clinical scenarios in ovarian cancer. The goal is to enhance clinicians’ understanding of the role of parp inhibitors and support evidence-based, patient-centered therapeutic choices.